These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12454512)

  • 1. VEGF-RII influences the prognosis of pancreatic cancer.
    Büchler P; Reber HA; Büchler MW; Friess H; Hines OJ
    Ann Surg; 2002 Dec; 236(6):738-49; discussion 749. PubMed ID: 12454512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer growth is inhibited by blockade of VEGF-RII.
    Büchler P; Reber HA; Ullrich A; Shiroiki M; Roth M; Büchler MW; Lavey RS; Friess H; Hines OJ
    Surgery; 2003 Nov; 134(5):772-82. PubMed ID: 14639356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer.
    Hotz B; Backer MV; Backer JM; Buhr HJ; Hotz HG
    Neoplasia; 2010 Oct; 12(10):797-806. PubMed ID: 20927318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.
    Hotz HG; Gill PS; Masood R; Hotz B; Buhr HJ; Foitzik T; Hines OJ; Reber HA
    J Gastrointest Surg; 2002; 6(2):159-66; discussion 166. PubMed ID: 11992800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
    Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
    Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
    Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M
    Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
    Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
    Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
    Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
    Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
    Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
    Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA
    Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
    Wei D; Le X; Zheng L; Wang L; Frey JA; Gao AC; Peng Z; Huang S; Xiong HQ; Abbruzzese JL; Xie K
    Oncogene; 2003 Jan; 22(3):319-29. PubMed ID: 12545153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
    Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
    Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
    Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.
    Büchler P; Reber HA; Roth MM; Shiroishi M; Friess H; Hines OJ
    Neoplasia; 2007 Feb; 9(2):119-27. PubMed ID: 17356708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.